Committees

Alain Beck
Senior Director, Biologics CMC & developability
Centre d’Immunologie Pierre Fabre

Thierry Wurch
Senior Director, Global External Innovation and Partnering in Oncology
Evotec

Ana Antunes
Head of Scientific Events and Communication
MabDesign

Jacques Dumas
Deputy Head Biologics Research Dpt. Vitry / Head of Protein Science & Technology
Sanofi

Nicolas Poirier
Chief Scientific Officer
OSE Immunotherapeutics

Paul Parren
Executive VP and Head of R&D
Lava Therapeutics, Netherlands

Lennart Zabeau
Senior Research Scientist
Orionis Biociences, Belgium

Hélène Negre
CMC Project Leader
SERVIER

Stéphanie Cornen
Director R&D
Innate Pharma

Pierre Martineau
Group Leader, Functional screening and targeting in cancer, and Deputy Director
Institut de Recherche en Cancérologie de Montpellier (IRCM), Montpellier
Deputy Coordinator
MabImprove
Founder
Mabqi

Mireia Pelegrin
Group Leader ANTIBODIES and IMMUNOMODULATION
Institute for Regenerative Medicine & biotherapy (IRMB)

Bruno Robert
Group Leader
IRCM
Founder
Mabqi

Martin Villalba
Group Leader Natural killer cell based immunotherapies: monoclonal antibodies and metabolism
Institute for Regenerative Medicine & biotherapy (IRMB)

Guillaume Cartron
Professor, Clinical Expert, Principal Investigator of clinical trials
CHU Montpellier – Hôpital Saint Eloi

Francis Duffieux
Principal Scientist, Head of Protein Purification, LMR Vitry
SANOFI

Nicolas Groux
CEO
MabDesign

Ana Antunes
Head of Scientific Events and Communication
MabDesign

Hervé Watier
Coordinator
LabEx MabImprove
Professor of Immunology
Faculty of Medicine of Tours
Head of Lab of Immunology
Univ. Hospital of Tours

Pierre Martineau
Group Leader, Functional screening and targeting in cancer, and Deputy Director
Institut de Recherche en Cancérologie de Montpellier (IRCM), Montpellier
Deputy Coordinator
MabImprove
Founder
Mabqi